S2 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases حسب Feng Gao (3548)

S4 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases حسب Feng Gao (3548)

S6 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases حسب Feng Gao (3548)

S5 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases حسب Feng Gao (3548)

S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases حسب Feng Gao (3548)

Average percent relative abundance of top 10 most abundance species of healthy control and stroke patient groups. حسب Duangnapa Roongpiboonsopit (12829198)

الموضوعات:

Microbiota compositions in percent relative abundance between healthy control and stroke patient individuals (the average microbiota between groups were displayed on the rightmost... حسب Duangnapa Roongpiboonsopit (12829198)

الموضوعات:

IFA reduced the capsular biosynthesis through altering bacterial metabolism. حسب Tingting Wang (123983)

Heat shock induced alterations in the production of viral progeny and baculovirus genomes. حسب Enrique Paz-Cortés (20988196)

Electroretinogram (ERG) recordings from 6-, 9-, and 12-month mice show deficits in 5xFAD photoreceptors. حسب Shaylah McCool (20818280)

"…<p>(A) Example ERG traces from C57 (black) and 5xFAD (blue) mice at 3 timepoints show waveforms produced by 9 stimulus intensities ranging from 0.0005–3.0000 cd * s/m². (B) Significantly altered A- and B-wave amplitudes are seen in the 6- and 9-month 5xFAD mice. …"

Oscillatory potential (OP) analysis of 6-, 9-, and 12-month ERGs shows continued dysfunction in the inner retina reflecting A- and B-wave results. حسب Shaylah McCool (20818280)

NeuN staining of 6-, 9-, and 12-month dLGN sections shows loss of thalamocortical cell bodies in the 5xFAD mice. حسب Shaylah McCool (20818280)

Ni causes a decrease in membrane sterols in A549 lung epithelial cells. حسب Amber R. Matha (19681603)

Properties of differential lipids that have increased and decreased abundance in the BmNPV-infected group of head samples at 96 hpi. حسب Min Feng (141118)

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. حسب Michael Gulledge (20577135)

الموضوعات:

Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"

Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"

Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"

Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"

Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"